Piperonal

Piperonal

SCHEMBL1864802

O=Cc1ccc2c(c1)OCO2.O=Cc1ccc2c(c1)OCO2

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 1.00
TDP1 Q9NUW8 3/20 1.00
HSD17B10 Q99714 2/20 1.00
CYP3A4 P08684 1/20 0.60
ATM Q13315 1/20 0.60
CYP19A1 P11511 2/20 0.56
NPC1 O15118 1/20 0.56
MTOR P42345 1/20 0.56
RAB9A P51151 1/20 0.56
VCP P55072 1/20 0.56
MAPT P10636 4/20 0.54
KMT2A Q03164 2/20 0.54
LMNA P02545 1/20 0.54
MAPK1 P28482 1/20 0.54
MEN1 O00255 1/20 0.54
KDM4E B2RXH2 2/20 0.53
DYRK1A Q13627 1/20 0.53
DYRK2 Q92630 1/20 0.53
DYRK1B Q9Y463 1/20 0.53
CYP1A2 P05177 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Piperonal SCHEMBL29318 1.00 ALDH1A1 (1.00) ALDH1A1TDP1HSD17B10CYP3A4ATM
Piperonal SCHEMBL29411164 1.00 ALDH1A1 (1.00) ALDH1A1TDP1HSD17B10CYP3A4ATM
Piperonal SCHEMBL28017062 0.98 ALDH1A1 (0.96) ALDH1A1TDP1HSD17B10CYP3A4ATM
Piperonal SCHEMBL5958791 0.98 ALDH1A1 (0.96) ALDH1A1TDP1HSD17B10CYP3A4ATM
Piperonal SCHEMBL28534378 0.92 ALDH1A1 (0.85) ALDH1A1TDP1HSD17B10CYP3A4ATM
Piperonal SCHEMBL9007249 0.91 ALDH1A1 (0.82) ALDH1A1TDP1HSD17B10CYP3A4ATM
Piperonal SCHEMBL16318685 0.91 ALDH1A1 (0.82) ALDH1A1TDP1HSD17B10CYP3A4ATM
Piperonal SCHEMBL16161395 0.91 ALDH1A1 (0.82) ALDH1A1TDP1HSD17B10CYP3A4ATM
Piperonal SCHEMBL10816820 0.91 ALDH1A1 (0.82) ALDH1A1TDP1HSD17B10CYP3A4ATM
Piperonal SCHEMBL1774149 0.91 ALDH1A1 (0.82) ALDH1A1TDP1HSD17B10CYP3A4ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11062794-B2 Olfactory signature and odorant mixture having the same YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2021-07-13 US disclosed
EP-3618798-A1 COMPOSITION FOR ODOUR IMPROVEMENT Symrise AG (DE) 2020-03-11 EP disclosed
US-20180253534-A1 OLFACTORY SIGNATURE AND ODORANT MIXTURE HAVING THE SAME YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2018-09-06 US disclosed
EP-3365418-A2 PARTICLES FOR MALODOR REDUCTION The Procter and Gamble Company (US) 2018-08-29 EP disclosed
EP-3307231-A1 FRAGRANCE COMPOSITIONS AND USES THEREOF The Procter and Gamble Company (US) 2018-04-18 EP disclosed
EP-3307393-A1 FRAGRANCE COMPOSITION The Procter and Gamble Company (US) 2018-04-18 EP disclosed
EP-3307394-A1 FRAGRANCE FIXATIVES AND COMPOSITIONS COMPRISING THEREOF The Procter and Gamble Company (US) 2018-04-18 EP disclosed
EP-3197511-A1 PERSONAL CARE COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2017-08-02 EP disclosed
EP-3197423-A1 PRODUCTS COMPRISING MALODOR REDUCTION MATERIALS THE PROCTER & GAMBLE COMPANY (US) 2017-08-02 EP disclosed
EP-3197426-A1 FRESHENING COMPOSITIONS AND DEVICES COMPRISING SAME THE PROCTER & GAMBLE COMPANY (US) 2017-08-02 EP disclosed
WO-2015050915-A1 COMPOSITIONS COMPRISING POLYAMINE POLYMER COMPATIBLE PERFUME MATERIALS THE PROCTER & GAMBLE COMPANY (US) 2015-04-09 WO disclosed
WO-2015050916-A1 COMPOSITIONS COMPRISING HYDROPHOBICALLY MODIFIED POLYAMINE POLYMER COMPATIBLE PERFUME MATERIALS THE PROCTER & GAMBLE COMPANY (US) 2015-04-09 WO disclosed
CN-103936709-A Synthetic method of piperonal LI DONGFENG 2014-07-23 CN disclosed
WO-2013035070-A1 OLFACTORY SIGNATURE AND ODORANT MIXTURE HAVING THE SAME YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2013-03-14 WO disclosed
EP-2496682-A1 DELIVERY PARTICLE The Procter & Gamble Company (US) 2012-09-12 EP disclosed
WO-2011056935-A1 DELIVERY PARTICLE THE PROCTER & GAMBLE COMPANY (US) 2011-05-12 WO disclosed
WO-2010117740-A2 ENHANCED FORMULATIONS, COMPOSITIONS AND METHODS FOR PEST CONTROL TYRATECH, INC. (US) 2010-10-14 WO disclosed
EP-2073632-A1 SYNERGISTIC PEST-CONTROL COMPOSITIONS Tyratech, Inc. (US) 2009-07-01 EP disclosed
WO-2009038599-A1 SYNERGISTIC PEST-CONTROL COMPOSITIONS TYRATECH, INC. (US) 2009-03-26 WO disclosed
US-20080044487-A1 Anti-inflammatory properties of marine lipid compositions NATURAL ASA (NO) 2008-02-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080044487-A1 Anti-inflammatory properties of marine lipid compositions PTGES3, ELOVL3, PTGER3 ALDH1A1 4001/4885TDP1 2890/4885HSD17B10 1285/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.